Sullivan, B A
Tsuji, W
Kivitz, A
Peng, J
Arnold, G E
Boedigheimer, M J
Chiu, K
Green, C L
Kaliyaperumal, A
Wang, C
Ferbas, J
Chung, J B
Clinical trials referenced in this document:
Documents that mention this clinical trial
Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus
https://doi.org/10.1136/lupus-2016-000146
Funding for this research was provided by:
Amgen